Interaction Checker

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Anticoagulants and Antiplatelets

Tuesday 07 June 2016

Four new comedications have been added to the Anticoagulants, Antiplatelets and Fibrinolytic class. The new drugs are apixaban, dipyridamole, edoxaban and fondaparinux. All versions of the interaction charts (web, app and printable) have been updated with these new additions.

In related news, a new treatment selector for the class of Anticoagulants and Antiplatelets has been produced. Treatment selectors show interactions between key antiretrovirals and are designed to quickly show which antiretrovirals and co-medications are ‘more risky’ in relation to drug interactions. The new treatment can be found in the Interaction Charts | Treatment Selector section of the website.

SPONSORS
Sponsor logo janssen Sponsor logo gilead Sponsor logo msd Sponsor logo viiv
EDITORIAL SPONSORS
Hiv  glasgow 2018 cmyk logo Eacs logo 2014 Bhiva 2018 Basel text
Awards and commendations
bma-foundation-for-medical-research british-medical-journal-2018 queens_aniversary_prize_2017 rcp-excellence-patient-care-awards-2017 rcp-excellence-patient-care-awards-2017 building_better_healthcare_awards_2016